HEM:CC Message Board Post 7148462 | Hemostemix Inc.
home / stock / hem:cc / hem:cc message board
royjame8765
Member
Posted on: Apr/18/2023 08:16:04
Source: mwn
The proprietary technology of Hemostemix ($HEM) includes methods for collecting the synergetic cell population and manufacturing (isolation, enrichment, and differentiation) a personalised regenerative therapy that can be administered to a patient within 7 days of the initial cell collection. There are 81,089,626 outstanding shares of listed stock.
News, Short Squeeze, Breakout and More Instantly...
Hemostemix Inc. Company Name:
HEM:CC Stock Symbol:
Market:
-
A look at the top 10 most actives in Canada Royal Bank of Canada (RY) fell 0.9% to $135.13 on volume of 3,757,883 shares Rogers Communications Inc. Class B Non-voting Shares (RCI.B) fell 0.5% to $53.81 on volume of 3,042,339 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 7...
-
Calgary, Alberta--(Newsfile Corp. - March 7, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. ("OHAM"), an Exempt Market Dealer to provide capital markets advice rel...
-
Calgary, Alberta--(Newsfile Corp. - February 6, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company's Phase II randomized clinical trial results ...